ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japanese Pharmacology & Therapeutics(JPT)

Vol. 35 Suppl. 2 2007

■ Preclinical and Clinical Studies of Oral Pilocarpine Hydrochloride, for the Treatment of Xerostomia

Effect of pilocarpine hydrochloride(SALAGEN® Tab. 5mg)on salivary secretion in Sjogen's syndrome model mouse

T. Asari, et al.

Jpn Pharmacol Ther 2007 35(s2) s111-22


Clinical pharmacology study of oral pilocarpine in the non-elderly healthy male

T. Hasunuma, et al.

Jpn Pharmacol Ther 2007 35(s2) s123-30


Oral pilocarpine for radiation-induced xerostomia
─A randomized, double-blind, placebo-controlled trial─

A. Konno, et al.

Jpn Pharmacol Ther 2007 35(s2) s131-40


Dose-finding study of oral pilocarpine for the treatment of xerostomia associated with Sjogen's syndrome

S. Sugai, et al.

Jpn Pharmacol Ther 2007 35(s2) s141-53


Long-term study of oral pilocarpine for the treatment of xerostomia associated with Sjogen's syndrome

S. Sugai, et al.

Jpn Pharmacol Ther 2007 35(s2) s155-67